Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Immunogenicity and Booster of SA-14-14-2 JE Vaccine in Children
NCT02514746Phase 4Completed
- Sponsor
- PATH
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by PATH. Started Jul 2015; status: completed.
02
Drugs
japanese encephalitis vaccine sa14-14-2
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT02514746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514746.